ADMA Bio (ADMA) Operatsion marja

ADMA Biologics (ADMA) korporativ emblemasi va logotipi

Operatsion marja qiymati biologik preparatlarni tashish paytidagi qat'iy harorat nazorati bilan bog'liq va joriy parametr 44.90 hisoblanadi. ADMA Biologics (ADMA) kompaniyasidagi samarali boshqaruv plazma markazlarining shaffof o'sishini va barqaror foydani ta'minladi. Yuqori toifali immunologlar jamoasi hayotni saqlovchi dori vositalarini yaratish ijtimoiy missiyasiga bag'ishlangan bo'lib, bu kompaniyaning ichki madaniyatini mustahkamlaydi.

ADMA - admabiologics.com Operatsion foyda normasi 04.07.2022 - 19.11.2026 oraligʻida

ADMA (admabiologics.com): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:ADMA, ADMA Bio
ADMA Biologics tayyor mahsulotlari

Professional menejerlar operatsion marja orqali xarajatlarni boshqarish samaradorligini baholab, barqaror aktivlarni spekulyativ aktivlardan ajratish uchun fundamental filtrlardan foydalanadilar. Ushbu ko'rsatkich soliqlar va foizlardan oldingi asosiy operatsiyalardan olingan foyda ulushini o'lchaydi, bu esa ADMA Biologics (ADMA) holatida yopiq immunoglobulin ishlab chiqarish ekotizimining monetizatsiyasi va plazmaning bozordagi tanqisligini tasdiqlab, uning asosiy biznesi daromadliligidagi o'zgarishlarni aks ettiradi.

Muhim raqobatchilar

ARGX (argenx N.V.) - Operatsion marja|Sotuvning operatsion rentabelligi BioNTech Pharma BNTX|Sotuvning operatsion marjasi ABVX (ABIVAX)|Operatsion foyda koeffitsiyenti PTGX|Operatsion rentabellik Immunovant Corp IMVT|Operatsion marja Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Operatsion rentabellik|Operatsion faoliyat rentabelligi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Sotuvning operatsion marjasi|Aurinia Pharmaceuticals Inc. (AUPH) - Operatsion marja|Sotuvning operatsion marjasi BCRX|Sotuvning operatsion rentabelligi Vera Therapeutics Inc VERA|Sotuvning operatsion marjasi DNTH (Dianthus Pharma)|Operatsion faoliyat rentabelligi Pharvaris N.V.|AbCellera Biologics Inc - Sotuvning operatsion marjasi|Tourmaline Bio (TRML) - Sotuvning operatsion rentabelligi|PGEN - Operatsion rentabellik|Operatsion foyda normasi PHAR (Pharming Group NV)|NKTR: Operatsion marja|Upstream Bio Corp - Operatsion foyda normasi|Operatsion rentabellik Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Operatsion faoliyat rentabelligi|Operatsion marja GOSS|Sotuvning operatsion marjasi KalVista Pharmaceuticals, Inc. KALV|Operatsion rentabellik Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Sotuvning operatsion rentabelligi|SVRA - Operatsion rentabellik|Rigel Pharmaceuticals - Operatsion foyda koeffitsiyenti|AnaptysBio Corp (ANAB) - Operatsion rentabellik|ATXS - Operatsion faoliyat rentabelligi|Operatsion rentabellik enGene Holdings Inc.|RAPT: Operatsion foyda normasi|Operatsion marja JBIO|Sotuvning operatsion marjasi aclaristx.com ACRS|Operatsion rentabellik Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Sotuvning operatsion rentabelligi|Cabaletta Bio, Inc - Operatsion marja|Sotuvning operatsion rentabelligi Ventyx Biosciences|THTX (theratech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Operatsion marja|Sotuvning operatsion rentabelligi Agenus Inc. AGEN|Sotuvning operatsion marjasi CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Operatsion foyda normasi|Operatsion rentabellik atyrpharma.com ATYR|Operatsion marja Adagene Corp ADAG|IMA - Operatsion rentabellik|Operatsion foyda normasi STTK (Shattuck Labs)|EQ: Operatsion marja|Connect Biopharma (CNTB) - Operatsion marja|Operatsion rentabellik Immunic|Operatsion marja atarabio.com|Operatsion marja IFRX|Operatsion marja X4 Pharma (XFOR)|Operatsion marja ACET (adicetbio.com)|Operatsion marja Celularity Inc. CELU|INMB - Operatsion rentabellik|Operatsion foyda normasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi SAB Biotherapeutics Inc.|Sotuvning operatsion marjasi AKTX|Sotuvning operatsion marjasi enlivex.com (ENLV)|Operatsion rentabellik Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operatsion foyda bo'yicha marjinallik|Operatsion marja EDSA (Edesa Biotech Corp)|Operatsion faoliyat rentabelligi iBio (IBIO)|CARM - Operatsion rentabellik|XTL Biopharmaceuticals (XTLB) - Sotuvning operatsion marjasi|BOLT: Operatsion marja|Sotuvning operatsion marjasi HCW Biologics Inc.|Operatsion rentabellik Aptevo|Operatsion foyda bo'yicha sotuv rentabelligi AIM (AIM ImmunoTech, Inc.)|Operatsion marja ADTX|Operatsion faoliyat rentabelligi GRI Bio Corp|Operatsion marja XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Sotuvning operatsion rentabelligi|Revelation Biosciences Corp - Operatsion marja|INDP (Indaptus Therapeutics, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|SCNI: Operatsion marja|CALI - Operatsion faoliyat rentabelligi|AFMD (Affimed N.V.) - Operatsion marja|Operatsion rentabellik ALLK|Sotuvning operatsion marjasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Sotuvning operatsion rentabelligi|Operatsion rentabellik iTeos ITOS|Ocean Bio - Operatsion rentabellik|TC BioPharm Ltd - Operatsion marja|Sotuvning operatsion rentabelligi thirdharmonicbio.com